160 related articles for article (PubMed ID: 33080064)
1. Eltrombopag as first-line treatment for thrombocytopenia among paediatric patients after allogeneic haematopoietic stem cell transplantation.
Qiu KY; Liao XY; Huang K; Wu RH; Xu HG; Xu LH; Li Y; Weng WJ; Zhou DH; Fang JP
Br J Clin Pharmacol; 2021 Apr; 87(4):2023-2031. PubMed ID: 33080064
[TBL] [Abstract][Full Text] [Related]
2. Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation.
Tanaka T; Inamoto Y; Yamashita T; Fuji S; Okinaka K; Kurosawa S; Kim SW; Tanosaki R; Fukuda T
Biol Blood Marrow Transplant; 2016 May; 22(5):919-24. PubMed ID: 26785333
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation.
Karataş A; Göker H; Demiroğlu H; Malkan ÜY; Velet M; Çınar OE; Erdoğdu B; Karadeniz M; Sayınalp N; Aksu S; Haznedaroğlu İC; Özcebe Oİ; Büyükaşık Y
Turk J Med Sci; 2022 Apr; 52(2):413-419. PubMed ID: 36161632
[TBL] [Abstract][Full Text] [Related]
4. Eltrombopag for Treatment of Thrombocytopenia Following Hematopoietic Stem Cell Transplantation.
Güven ZT; Çelik S; Eser B; Çetin M; Ünal A; Kaynar L
Turk J Haematol; 2022 Jun; 39(2):103-108. PubMed ID: 35297243
[TBL] [Abstract][Full Text] [Related]
5. Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children.
Ali S; Gassas A; Kirby-Allen M; Krueger J; Ali M; Schechter T
Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28653480
[TBL] [Abstract][Full Text] [Related]
6. Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation in children: Single-centre experience.
Yaman Y; Elli M; Şahin Ş; Özdilli K; Bilgen H; Bayram N; Nepesov S; Anak S
Pediatr Transplant; 2021 Aug; 25(5):e13962. PubMed ID: 33452850
[TBL] [Abstract][Full Text] [Related]
7. [Eltrombopag for thrombocytopenia in 24 children after hematopoietic stem cell transplantation].
Liu S; Que LP; Huang K; Fang JP; Wang KM; Zhan LP; Liu DD; Xu HG
Zhonghua Er Ke Za Zhi; 2021 Apr; 59(4):311-315. PubMed ID: 33775051
[No Abstract] [Full Text] [Related]
8. Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation.
Fu H; Zhang X; Han T; Mo X; Wang Y; Chen H; Han W; Wang J; Wang F; Yan C; Zhang Y; Sun Y; Liu K; Huang X; Xu L
Bone Marrow Transplant; 2019 Aug; 54(8):1310-1318. PubMed ID: 30664724
[TBL] [Abstract][Full Text] [Related]
9. [Eltrombopag for refractory thrombocytopenia in patients with allogeneic hematopoietic stem cell transplantation].
Ma YR; Huang XJ; Mo XD; Han W; Yan CH; Chen Y; Ji Y; Chen YY; Wang Y; Zhang XH; Liu KY; Xu LP
Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1065-1069. PubMed ID: 28088971
[TBL] [Abstract][Full Text] [Related]
10. Eltrombopag for thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children.
Masetti R; Vendemini F; Quarello P; Girardi K; Prete A; Fagioli F; Pession A; Locatelli F
Pediatr Blood Cancer; 2020 May; 67(5):e28208. PubMed ID: 32065469
[TBL] [Abstract][Full Text] [Related]
11. Eltrombopag for Delayed Platelet Recovery and Secondary Thrombocytopenia Following Allogeneic Stem Cell Transplantation in Children.
Li S; Wu R; Wang B; Fu L; Zhu G; Zhou X; Ma J; Zhang L; Qin M
J Pediatr Hematol Oncol; 2019 Jan; 41(1):38-41. PubMed ID: 30080752
[TBL] [Abstract][Full Text] [Related]
12. Eltrombopag in the treatment of patients with persistent thrombocytopenia after haploidentical peripheral blood stem cell transplantation: a single-center experience.
Yan F; Lu N; Gu Z; Huang W; Wang S; Gao X; Dou L; Li F; Wang L; Li M; Liu D; Gao C
Ann Hematol; 2022 Feb; 101(2):397-408. PubMed ID: 34735613
[TBL] [Abstract][Full Text] [Related]
13. Eltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell Transplantation.
Yuan C; Boyd AM; Nelson J; Patel RD; Varela JC; Goldstein SC; Ahmad S; Zhu X; Mori S
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1320-1324. PubMed ID: 30710685
[TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant.
Bento L; Bastida JM; García-Cadenas I; García-Torres E; Rivera D; Bosch-Vilaseca A; De Miguel C; Martínez-Muñoz ME; Fernández-Avilés F; Roldán E; Chinea A; Yáñez L; Zudaire T; Vaz CP; Espigado I; López J; Valcárcel D; Duarte R; Cabrera R; Herrera C; González-Porras JR; Gutiérrez A; Solano C; Sampol A;
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1825-1831. PubMed ID: 31152794
[TBL] [Abstract][Full Text] [Related]
15. Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non-inferiority, randomized controlled trial.
Wen B; Zhang X; Chen S; Fan J; Yang S; Cai Y; Wang P; Zhang Q; Gu Q; Du X
Hematol Oncol; 2022 Oct; 40(4):777-786. PubMed ID: 35554955
[TBL] [Abstract][Full Text] [Related]
16. Use of eltrombopag for the treatment of poor graft function after hematopoietic stem cell transplantation in children.
Uria-Oficialdegui ML; Alonso L; Benitez-Carabante MI; Renedo B; Oliveras M; Diaz-de-Heredia C
Pediatr Transplant; 2021 Jun; 25(4):e14010. PubMed ID: 33742757
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantation.
Nampoothiri RV; Ho L; McEwan C; Pasic I; Lam W; Law AD; Michelis FV; Thyagu S; Kim DDH; Gerbitz A; Viswabandya A; Lipton JH; Mattsson J; Kumar R
Bone Marrow Transplant; 2021 Oct; 56(10):2471-2476. PubMed ID: 34108675
[TBL] [Abstract][Full Text] [Related]
18. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.
Grainger JD; Locatelli F; Chotsampancharoen T; Donyush E; Pongtanakul B; Komvilaisak P; Sosothikul D; Drelichman G; Sirachainan N; Holzhauer S; Lebedev V; Lemons R; Pospisilova D; Ramenghi U; Bussel JB; Bakshi KK; Iyengar M; Chan GW; Chagin KD; Theodore D; Marcello LM; Bailey CK
Lancet; 2015 Oct; 386(10004):1649-58. PubMed ID: 26231455
[TBL] [Abstract][Full Text] [Related]
19. Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia.
Reid R; Bennett JM; Becker M; Chen Y; Milner L; Phillips GL; Liesveld J
Am J Hematol; 2012 Jul; 87(7):743-5. PubMed ID: 22573520
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Eltrombopag in Thrombocytopenia Post Hematopoietic Cell Transplantation: Rertrospective Observational Trial.
Samarkandi H; Al Nahedh M; Alfattani A; Alsharif F; Bakshi N; Rasheed W; Alfraih F; Alhumaid M; Alkhudair N; Alhayli S; Alsaedi H; Shaheen M; Hanbali A; Hashmi SK; Devol E; Alseraihy A; Alzahrani H; Aljurf M
Hematol Oncol Stem Cell Ther; 2022 Mar; 15(1):285-290. PubMed ID: 32755559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]